Evaluation of Pain Treatment After Total Knee Arthroplasty

Recruiting now · Phase 4 · Has a placebo group

Conditions studied: Pain

In brief

The purpose of the study is to characterize opioid use after total knee arthroplasty (TKA).

Key facts

Study ID

NCT07538570

Run by

Vertex Pharmaceuticals Incorporated

People needed

60

Starts

2026-04-24

Expected to finish

2027-01-30

Last updated by the study team

2026-05-13

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Legent Orthopedic and Spine Hospital — Bellaire, Texas, United States (enrolling)
• Memorial Hermann Village Office — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.